Comparison of gastric cancer statistics in China and Japan based on the GLOBOCAN and CI5Plus databases

Introduction Gastric cancer (GC) is a major global public health burden. In this comparative ecological study, we used the 2022 Global Cancer Observatory (GLOBOCAN) database to compare the national GC burden between China and Japan and the Cancer Incidence in Five Continents Plus (CI5Plus) database to determine the registry-based incidence trends from 1993 to 2017. Methods Age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) for 2022 were obtained from GLOBOCAN, and the registry-based GC incidence data from 1993 to 2017 were obtained from CI5Plus. The association between socioeconomic development and GC burden was assessed using the Human Development Index (HDI), and autoregressive integrated moving average (ARIMA) models were established to predict GC incidence from 2018 to 2050. Results In 2022, Japan had a higher GC ASIR in the general population (27.60 vs. 13.72 per 100,000), whereas China had a higher ASMR (9.39 vs. 7.24 per 100,000). Males exhibited a higher incidence and mortality in both countries. From 1993 to 2017, China displayed a pattern of rapid decline, brief increase, and subsequent steady decrease in GC incidence, whereas Japan exhibited an initial decline followed by heterogeneous subsequent patterns, including statistically significant upward segments in selected overall, sexspecific, and age-specific series. Higher HDI levels were inversely associated with GC incidence, suggesting a potential relationship between socioeconomic development and GC burden. ARIMA-based projections suggested stable GC incidence patterns through 2050, with a slight decrease observed in the overall Japanese population. Discussion China and Japan showed distinct temporal patterns of GC incidence and mortality. These differences may reflect variations in screening practices, healthcare systems, and socioeconomic development between the two countries, which provide a foundation for future GC control strategies.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-17
DOI
https://doi.org/10.3389/fonc.2026.1929870
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparison of gastric cancer statistics in China and Japan based on the GLOBOCAN and CI5Plus databases

Shaowei Xiong, Guoqing Lv, Sheng Ao, Haoran Zhang et al.
5 links
Frontiers in Oncology
Global Cancer Incidence and Screening
article

Comparison of gastric cancer statistics in China and Japan based on the GLOBOCAN and CI5Plus databases

Shaowei Xiong, Guoqing Lv, Sheng Ao, Haoran Zhang, Yuchen Wang, Jun Luo, Chang Yan, Yangyang Xue, Jiyan Xie, Shuang Liu, Jianing Hou
article en

Abstract

Introduction Gastric cancer (GC) is a major global public health burden. In this comparative ecological study, we used the 2022 Global Cancer Observatory (GLOBOCAN) database to compare the national GC burden between China and Japan and the Cancer Incidence in Five Continents Plus (CI5Plus) database to determine the registry-based incidence trends from 1993 to 2017. Methods Age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) for 2022 were obtained from GLOBOCAN, and the registry-based GC incidence data from 1993 to 2017 were obtained from CI5Plus. The association between socioeconomic development and GC burden was assessed using the Human Development Index (HDI), and autoregressive integrated moving average (ARIMA) models were established to predict GC incidence from 2018 to 2050. Results In 2022, Japan had a higher GC ASIR in the general population (27.60 vs. 13.72 per 100,000), whereas China had a higher ASMR (9.39 vs. 7.24 per 100,000). Males exhibited a higher incidence and mortality in both countries. From 1993 to 2017, China displayed a pattern of rapid decline, brief increase, and subsequent steady decrease in GC incidence, whereas Japan exhibited an initial decline followed by heterogeneous subsequent patterns, including statistically significant upward segments in selected overall, sexspecific, and age-specific series. Higher HDI levels were inversely associated with GC incidence, suggesting a potential relationship between socioeconomic development and GC burden. ARIMA-based projections suggested stable GC incidence patterns through 2050, with a slight decrease observed in the overall Japanese population. Discussion China and Japan showed distinct temporal patterns of GC incidence and mortality. These differences may reflect variations in screening practices, healthcare systems, and socioeconomic development between the two countries, which provide a foundation for future GC control strategies.

Frontiers in OncologyVol. 16
Peking University Shenzhen Hospital (CN)
Good health and well-being
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon